nodes	percent_of_prediction	percent_of_DWPC	metapath
Sufentanil—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0602	0.332	CbGbCtD
Sufentanil—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.056	0.308	CbGbCtD
Sufentanil—Shivering—Tretinoin—peripheral nervous system neoplasm	0.0349	0.0431	CcSEcCtD
Sufentanil—Shivering—Isotretinoin—peripheral nervous system neoplasm	0.0349	0.0431	CcSEcCtD
Sufentanil—Shivering—Alitretinoin—peripheral nervous system neoplasm	0.0265	0.0327	CcSEcCtD
Sufentanil—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0257	0.142	CbGbCtD
Sufentanil—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0235	0.13	CbGbCtD
Sufentanil—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0161	0.0885	CbGbCtD
Sufentanil—Euphoric mood—Tretinoin—peripheral nervous system neoplasm	0.0112	0.0138	CcSEcCtD
Sufentanil—Euphoric mood—Isotretinoin—peripheral nervous system neoplasm	0.0112	0.0138	CcSEcCtD
Sufentanil—Laryngospasm—Etoposide—peripheral nervous system neoplasm	0.0103	0.0127	CcSEcCtD
Sufentanil—Apnoea—Etoposide—peripheral nervous system neoplasm	0.00909	0.0112	CcSEcCtD
Sufentanil—Cardiac arrest—Topotecan—peripheral nervous system neoplasm	0.00906	0.0112	CcSEcCtD
Sufentanil—Cardiac arrest—Tretinoin—peripheral nervous system neoplasm	0.00899	0.0111	CcSEcCtD
Sufentanil—Cardiac arrest—Isotretinoin—peripheral nervous system neoplasm	0.00899	0.0111	CcSEcCtD
Sufentanil—Cardiac arrest—Melphalan—peripheral nervous system neoplasm	0.00887	0.0109	CcSEcCtD
Sufentanil—Euphoric mood—Alitretinoin—peripheral nervous system neoplasm	0.00848	0.0105	CcSEcCtD
Sufentanil—Bronchospasm—Isotretinoin—peripheral nervous system neoplasm	0.00803	0.00991	CcSEcCtD
Sufentanil—Bronchospasm—Tretinoin—peripheral nervous system neoplasm	0.00803	0.00991	CcSEcCtD
Sufentanil—Bronchospasm—Melphalan—peripheral nervous system neoplasm	0.00793	0.00978	CcSEcCtD
Sufentanil—Cardiac arrest—Alitretinoin—peripheral nervous system neoplasm	0.00681	0.0084	CcSEcCtD
Sufentanil—Cardiac arrest—Vincristine—peripheral nervous system neoplasm	0.00656	0.00809	CcSEcCtD
Sufentanil—Urinary retention—Vincristine—peripheral nervous system neoplasm	0.00656	0.00809	CcSEcCtD
Sufentanil—Urinary tract disorder—Tretinoin—peripheral nervous system neoplasm	0.00646	0.00796	CcSEcCtD
Sufentanil—Urinary tract disorder—Isotretinoin—peripheral nervous system neoplasm	0.00646	0.00796	CcSEcCtD
Sufentanil—Urethral disorder—Tretinoin—peripheral nervous system neoplasm	0.00641	0.00791	CcSEcCtD
Sufentanil—Urethral disorder—Isotretinoin—peripheral nervous system neoplasm	0.00641	0.00791	CcSEcCtD
Sufentanil—Urinary tract disorder—Melphalan—peripheral nervous system neoplasm	0.00637	0.00786	CcSEcCtD
Sufentanil—Urethral disorder—Melphalan—peripheral nervous system neoplasm	0.00633	0.0078	CcSEcCtD
Sufentanil—Bronchospasm—Alitretinoin—peripheral nervous system neoplasm	0.00609	0.00751	CcSEcCtD
Sufentanil—Chills—Topotecan—peripheral nervous system neoplasm	0.00591	0.00729	CcSEcCtD
Sufentanil—Chills—Isotretinoin—peripheral nervous system neoplasm	0.00587	0.00724	CcSEcCtD
Sufentanil—Chills—Tretinoin—peripheral nervous system neoplasm	0.00587	0.00724	CcSEcCtD
Sufentanil—Arrhythmia—Isotretinoin—peripheral nervous system neoplasm	0.00584	0.0072	CcSEcCtD
Sufentanil—Arrhythmia—Tretinoin—peripheral nervous system neoplasm	0.00584	0.0072	CcSEcCtD
Sufentanil—Arrhythmia—Melphalan—peripheral nervous system neoplasm	0.00577	0.00711	CcSEcCtD
Sufentanil—Alfentanil—ABCB1—peripheral nervous system neoplasm	0.00572	0.732	CrCbGaD
Sufentanil—Erythema—Tretinoin—peripheral nervous system neoplasm	0.00569	0.00702	CcSEcCtD
Sufentanil—Erythema—Isotretinoin—peripheral nervous system neoplasm	0.00569	0.00702	CcSEcCtD
Sufentanil—Cardiac arrest—Etoposide—peripheral nervous system neoplasm	0.00532	0.00656	CcSEcCtD
Sufentanil—Injection site pain—Epirubicin—peripheral nervous system neoplasm	0.00529	0.00652	CcSEcCtD
Sufentanil—Hypertension—Isotretinoin—peripheral nervous system neoplasm	0.00491	0.00606	CcSEcCtD
Sufentanil—Hypertension—Tretinoin—peripheral nervous system neoplasm	0.00491	0.00606	CcSEcCtD
Sufentanil—Urinary tract disorder—Alitretinoin—peripheral nervous system neoplasm	0.00489	0.00604	CcSEcCtD
Sufentanil—Injection site pain—Doxorubicin—peripheral nervous system neoplasm	0.00489	0.00604	CcSEcCtD
Sufentanil—Urethral disorder—Alitretinoin—peripheral nervous system neoplasm	0.00486	0.00599	CcSEcCtD
Sufentanil—Chills—Dactinomycin—peripheral nervous system neoplasm	0.00479	0.00591	CcSEcCtD
Sufentanil—Bronchospasm—Etoposide—peripheral nervous system neoplasm	0.00475	0.00586	CcSEcCtD
Sufentanil—Urinary tract disorder—Vincristine—peripheral nervous system neoplasm	0.00472	0.00582	CcSEcCtD
Sufentanil—Confusional state—Tretinoin—peripheral nervous system neoplasm	0.00468	0.00578	CcSEcCtD
Sufentanil—Confusional state—Isotretinoin—peripheral nervous system neoplasm	0.00468	0.00578	CcSEcCtD
Sufentanil—Anaphylactic shock—Topotecan—peripheral nervous system neoplasm	0.00468	0.00578	CcSEcCtD
Sufentanil—Urethral disorder—Vincristine—peripheral nervous system neoplasm	0.00468	0.00577	CcSEcCtD
Sufentanil—Erythema—Dactinomycin—peripheral nervous system neoplasm	0.00465	0.00574	CcSEcCtD
Sufentanil—Anaphylactic shock—Isotretinoin—peripheral nervous system neoplasm	0.00465	0.00573	CcSEcCtD
Sufentanil—Anaphylactic shock—Tretinoin—peripheral nervous system neoplasm	0.00465	0.00573	CcSEcCtD
Sufentanil—Anaphylactic shock—Melphalan—peripheral nervous system neoplasm	0.00458	0.00566	CcSEcCtD
Sufentanil—Tachycardia—Isotretinoin—peripheral nervous system neoplasm	0.00453	0.00559	CcSEcCtD
Sufentanil—Tachycardia—Tretinoin—peripheral nervous system neoplasm	0.00453	0.00559	CcSEcCtD
Sufentanil—Tachycardia—Melphalan—peripheral nervous system neoplasm	0.00447	0.00552	CcSEcCtD
Sufentanil—Chills—Alitretinoin—peripheral nervous system neoplasm	0.00445	0.00548	CcSEcCtD
Sufentanil—Arrhythmia—Alitretinoin—peripheral nervous system neoplasm	0.00443	0.00546	CcSEcCtD
Sufentanil—Hypotension—Tretinoin—peripheral nervous system neoplasm	0.00434	0.00535	CcSEcCtD
Sufentanil—Hypotension—Isotretinoin—peripheral nervous system neoplasm	0.00434	0.00535	CcSEcCtD
Sufentanil—Erythema—Alitretinoin—peripheral nervous system neoplasm	0.00431	0.00532	CcSEcCtD
Sufentanil—Bradycardia—Cisplatin—peripheral nervous system neoplasm	0.0043	0.0053	CcSEcCtD
Sufentanil—Hypotension—Melphalan—peripheral nervous system neoplasm	0.00428	0.00528	CcSEcCtD
Sufentanil—Urinary tract disorder—Cisplatin—peripheral nervous system neoplasm	0.00417	0.00514	CcSEcCtD
Sufentanil—Urethral disorder—Cisplatin—peripheral nervous system neoplasm	0.00414	0.0051	CcSEcCtD
Sufentanil—Somnolence—Isotretinoin—peripheral nervous system neoplasm	0.00413	0.00509	CcSEcCtD
Sufentanil—Somnolence—Tretinoin—peripheral nervous system neoplasm	0.00413	0.00509	CcSEcCtD
Sufentanil—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.00386	0.00476	CcSEcCtD
Sufentanil—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.00383	0.00472	CcSEcCtD
Sufentanil—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.00383	0.00472	CcSEcCtD
Sufentanil—Urinary tract disorder—Etoposide—peripheral nervous system neoplasm	0.00382	0.00471	CcSEcCtD
Sufentanil—Urethral disorder—Etoposide—peripheral nervous system neoplasm	0.00379	0.00468	CcSEcCtD
Sufentanil—Arrhythmia—Cisplatin—peripheral nervous system neoplasm	0.00377	0.00465	CcSEcCtD
Sufentanil—Hypertension—Alitretinoin—peripheral nervous system neoplasm	0.00372	0.00459	CcSEcCtD
Sufentanil—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.0037	0.00457	CcSEcCtD
Sufentanil—Erythema—Cisplatin—peripheral nervous system neoplasm	0.00368	0.00453	CcSEcCtD
Sufentanil—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.00367	0.00453	CcSEcCtD
Sufentanil—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.00367	0.00453	CcSEcCtD
Sufentanil—Hypertension—Vincristine—peripheral nervous system neoplasm	0.00359	0.00443	CcSEcCtD
Sufentanil—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.00355	0.00438	CcSEcCtD
Sufentanil—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.00352	0.00434	CcSEcCtD
Sufentanil—Chills—Etoposide—peripheral nervous system neoplasm	0.00347	0.00428	CcSEcCtD
Sufentanil—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00345	0.00426	CcSEcCtD
Sufentanil—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.00344	0.00424	CcSEcCtD
Sufentanil—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00342	0.00422	CcSEcCtD
Sufentanil—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00342	0.00422	CcSEcCtD
Sufentanil—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.00339	0.00418	CcSEcCtD
Sufentanil—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00338	0.00417	CcSEcCtD
Sufentanil—Pruritus—Topotecan—peripheral nervous system neoplasm	0.00331	0.00409	CcSEcCtD
Sufentanil—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.00329	0.00406	CcSEcCtD
Sufentanil—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.00329	0.00405	CcSEcCtD
Sufentanil—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.00329	0.00405	CcSEcCtD
Sufentanil—Pruritus—Melphalan—peripheral nervous system neoplasm	0.00324	0.004	CcSEcCtD
Sufentanil—Hypotension—Vincristine—peripheral nervous system neoplasm	0.00317	0.00391	CcSEcCtD
Sufentanil—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.00313	0.00386	CcSEcCtD
Sufentanil—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.00313	0.00386	CcSEcCtD
Sufentanil—Dizziness—Topotecan—peripheral nervous system neoplasm	0.0031	0.00382	CcSEcCtD
Sufentanil—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00307	0.00379	CcSEcCtD
Sufentanil—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00307	0.00379	CcSEcCtD
Sufentanil—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.003	0.0037	CcSEcCtD
Sufentanil—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.003	0.0037	CcSEcCtD
Sufentanil—Cardiac arrest—Epirubicin—peripheral nervous system neoplasm	0.00298	0.00368	CcSEcCtD
Sufentanil—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00298	0.00367	CcSEcCtD
Sufentanil—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00295	0.00364	CcSEcCtD
Sufentanil—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00295	0.00364	CcSEcCtD
Sufentanil—Rash—Topotecan—peripheral nervous system neoplasm	0.00295	0.00364	CcSEcCtD
Sufentanil—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00295	0.00364	CcSEcCtD
Sufentanil—Headache—Topotecan—peripheral nervous system neoplasm	0.00293	0.00362	CcSEcCtD
Sufentanil—Rash—Tretinoin—peripheral nervous system neoplasm	0.00293	0.00361	CcSEcCtD
Sufentanil—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00293	0.00361	CcSEcCtD
Sufentanil—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.00293	0.00361	CcSEcCtD
Sufentanil—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00293	0.00361	CcSEcCtD
Sufentanil—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00293	0.00361	CcSEcCtD
Sufentanil—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00292	0.0036	CcSEcCtD
Sufentanil—Headache—Tretinoin—peripheral nervous system neoplasm	0.00291	0.00359	CcSEcCtD
Sufentanil—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00291	0.00359	CcSEcCtD
Sufentanil—Hypertension—Etoposide—peripheral nervous system neoplasm	0.00291	0.00359	CcSEcCtD
Sufentanil—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.0029	0.00358	CcSEcCtD
Sufentanil—Rash—Melphalan—peripheral nervous system neoplasm	0.00289	0.00357	CcSEcCtD
Sufentanil—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00289	0.00356	CcSEcCtD
Sufentanil—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.0028	0.00346	CcSEcCtD
Sufentanil—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.0028	0.00345	CcSEcCtD
Sufentanil—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.00278	0.00343	CcSEcCtD
Sufentanil—Nausea—Topotecan—peripheral nervous system neoplasm	0.00278	0.00343	CcSEcCtD
Sufentanil—Confusional state—Etoposide—peripheral nervous system neoplasm	0.00277	0.00342	CcSEcCtD
Sufentanil—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00276	0.0034	CcSEcCtD
Sufentanil—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00276	0.0034	CcSEcCtD
Sufentanil—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	0.00276	0.0034	CcSEcCtD
Sufentanil—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.00275	0.00339	CcSEcCtD
Sufentanil—Nausea—Melphalan—peripheral nervous system neoplasm	0.00272	0.00336	CcSEcCtD
Sufentanil—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.00268	0.00331	CcSEcCtD
Sufentanil—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.00268	0.00331	CcSEcCtD
Sufentanil—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00259	0.0032	CcSEcCtD
Sufentanil—Hypotension—Etoposide—peripheral nervous system neoplasm	0.00257	0.00317	CcSEcCtD
Sufentanil—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.0025	0.00308	CcSEcCtD
Sufentanil—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.00249	0.00307	CcSEcCtD
Sufentanil—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.00247	0.00305	CcSEcCtD
Sufentanil—Somnolence—Etoposide—peripheral nervous system neoplasm	0.00244	0.00301	CcSEcCtD
Sufentanil—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00241	0.00298	CcSEcCtD
Sufentanil—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00239	0.00295	CcSEcCtD
Sufentanil—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.00237	0.00292	CcSEcCtD
Sufentanil—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00233	0.00287	CcSEcCtD
Sufentanil—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.00226	0.00279	CcSEcCtD
Sufentanil—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00226	0.00278	CcSEcCtD
Sufentanil—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00224	0.00277	CcSEcCtD
Sufentanil—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00224	0.00276	CcSEcCtD
Sufentanil—Rash—Alitretinoin—peripheral nervous system neoplasm	0.00222	0.00274	CcSEcCtD
Sufentanil—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00222	0.00274	CcSEcCtD
Sufentanil—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00221	0.00273	CcSEcCtD
Sufentanil—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.00221	0.00272	CcSEcCtD
Sufentanil—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00221	0.00272	CcSEcCtD
Sufentanil—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.00217	0.00268	CcSEcCtD
Sufentanil—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00216	0.00266	CcSEcCtD
Sufentanil—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.00214	0.00264	CcSEcCtD
Sufentanil—Rash—Vincristine—peripheral nervous system neoplasm	0.00214	0.00264	CcSEcCtD
Sufentanil—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00214	0.00264	CcSEcCtD
Sufentanil—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.00213	0.00262	CcSEcCtD
Sufentanil—Headache—Vincristine—peripheral nervous system neoplasm	0.00213	0.00262	CcSEcCtD
Sufentanil—Fentanyl—ABCB1—peripheral nervous system neoplasm	0.00209	0.268	CrCbGaD
Sufentanil—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00209	0.00258	CcSEcCtD
Sufentanil—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.00204	0.00252	CcSEcCtD
Sufentanil—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.00202	0.0025	CcSEcCtD
Sufentanil—Nausea—Vincristine—peripheral nervous system neoplasm	0.00201	0.00249	CcSEcCtD
Sufentanil—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.00198	0.00244	CcSEcCtD
Sufentanil—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.00197	0.00243	CcSEcCtD
Sufentanil—Chills—Epirubicin—peripheral nervous system neoplasm	0.00195	0.0024	CcSEcCtD
Sufentanil—Pruritus—Etoposide—peripheral nervous system neoplasm	0.00194	0.0024	CcSEcCtD
Sufentanil—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.00194	0.00239	CcSEcCtD
Sufentanil—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.00191	0.00235	CcSEcCtD
Sufentanil—Rash—Cisplatin—peripheral nervous system neoplasm	0.00189	0.00233	CcSEcCtD
Sufentanil—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00189	0.00233	CcSEcCtD
Sufentanil—Erythema—Epirubicin—peripheral nervous system neoplasm	0.00189	0.00233	CcSEcCtD
Sufentanil—Dizziness—Etoposide—peripheral nervous system neoplasm	0.00182	0.00224	CcSEcCtD
Sufentanil—Chills—Doxorubicin—peripheral nervous system neoplasm	0.0018	0.00222	CcSEcCtD
Sufentanil—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.00179	0.00221	CcSEcCtD
Sufentanil—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00178	0.0022	CcSEcCtD
Sufentanil—Vomiting—Etoposide—peripheral nervous system neoplasm	0.00175	0.00216	CcSEcCtD
Sufentanil—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.00175	0.00215	CcSEcCtD
Sufentanil—Rash—Etoposide—peripheral nervous system neoplasm	0.00173	0.00214	CcSEcCtD
Sufentanil—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.00173	0.00214	CcSEcCtD
Sufentanil—Headache—Etoposide—peripheral nervous system neoplasm	0.00172	0.00212	CcSEcCtD
Sufentanil—Nausea—Etoposide—peripheral nervous system neoplasm	0.00163	0.00201	CcSEcCtD
Sufentanil—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.00163	0.00201	CcSEcCtD
Sufentanil—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.00155	0.00192	CcSEcCtD
Sufentanil—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.00154	0.0019	CcSEcCtD
Sufentanil—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.00151	0.00186	CcSEcCtD
Sufentanil—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.0015	0.00185	CcSEcCtD
Sufentanil—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.00144	0.00178	CcSEcCtD
Sufentanil—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.00144	0.00177	CcSEcCtD
Sufentanil—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.00143	0.00176	CcSEcCtD
Sufentanil—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.00139	0.00172	CcSEcCtD
Sufentanil—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.00137	0.00169	CcSEcCtD
Sufentanil—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.00133	0.00164	CcSEcCtD
Sufentanil—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.00127	0.00157	CcSEcCtD
Sufentanil—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.00127	0.00156	CcSEcCtD
Sufentanil—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.00122	0.0015	CcSEcCtD
Sufentanil—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.00117	0.00145	CcSEcCtD
Sufentanil—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.00113	0.0014	CcSEcCtD
Sufentanil—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.00113	0.00139	CcSEcCtD
Sufentanil—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.00109	0.00134	CcSEcCtD
Sufentanil—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.00105	0.0013	CcSEcCtD
Sufentanil—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.00102	0.00126	CcSEcCtD
Sufentanil—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.00101	0.00124	CcSEcCtD
Sufentanil—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000979	0.00121	CcSEcCtD
Sufentanil—Rash—Epirubicin—peripheral nervous system neoplasm	0.000971	0.0012	CcSEcCtD
Sufentanil—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.00097	0.0012	CcSEcCtD
Sufentanil—Headache—Epirubicin—peripheral nervous system neoplasm	0.000965	0.00119	CcSEcCtD
Sufentanil—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000942	0.00116	CcSEcCtD
Sufentanil—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000915	0.00113	CcSEcCtD
Sufentanil—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000906	0.00112	CcSEcCtD
Sufentanil—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000899	0.00111	CcSEcCtD
Sufentanil—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000898	0.00111	CcSEcCtD
Sufentanil—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000893	0.0011	CcSEcCtD
Sufentanil—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000847	0.00104	CcSEcCtD
